Evidence map›Paper›PMID 41053917›Full record

ArticleJournal of cellular and molecular medicine2025

Zerumbone Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing the NLRP3/Caspase-1/GSDMD Signalling Pathway.

Yun-Jie Xu, Fei-Fei Fang, Guo-Qiang Zhao, Wei-Yan Yu, Hong-Yan Han, Hong Teng, Jun-Ning Lyu, Jian-Feng Wang

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yun-Jie XuZhejiang Chinese Medical University, Hangzhou, China.
Fei-Fei FangCollege of Medicine, Shaoxing Vocational & Technology College, Shaoxing, China.
Guo-Qiang ZhaoDepartment of Obstetrics and Gynecology, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
Wei-Yan YuDepartment of Obstetrics and Gynecology, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
Hong-Yan HanDepartment of Respiratory Medicine, Shaoxing Second Hospital, Shaoxing, China.
Hong TengDepartment of Respiratory Medicine, Shaoxing Second Hospital, Shaoxing, China.
Jun-Ning LyuDepartment of Applied Statistics, Sydney Smart Technology College, Northeastern University at Qinhuangdao, Qinhuangdao, China.
Jian-Feng WangDepartment of Respiratory Diseases, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.ORCID 0000-0002-6316-6361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cyclic sesquiterpene with 11 carbon atoms is the primary component of essential oils from the wild ginger species, Zingiber zerumbet. It exhibits pharmacological effects, including anti-inflammatory and antioxidant properties. However, limited information exists regarding its role in pyroptosis during acute lung injury (ALI). Herein, we investigated how zingerone affects pyroptosis in a murine lipopolysaccharide (LPS)-induced ALI model established via intraperitoneal zerumbone (Zer) administration. Bronchoalveolar lavage fluid, serum, and lung tissue samples were collected after 24 h. Haematoxylin and eosin staining was performed to assess lung tissue damage. Western blot analysis and real-time quantitative polymerase chain reaction (qRT-PCR) were used to quantify protein expression levels associated with pyroptosis. Before LPS exposure, mouse alveolar epithelial (MLE)-12 cells were pretreated with 10 μM Zer for 2 h and then incubated with 1 ng/mL LPS for an additional 24 h. Zer treatment reduced lung tissue injury, inflammation, and oxidative stress in model mice. Zer counteracted pyroptosis in the alveolar epithelial cells of these mice. In MLE-12 cells, Zer significantly inhibited oxidative stress and inflammation. Zer suppressed NLRP3/Caspase-1/GSDMD signalling, pivotal in pyroptosis, mitigating ALI progression. A potential novel therapeutic agent for ALI inhibited the NLRP3/GSDMD signalling pathway involved in pyroptosis.

Indexed as

Acute Lung InjuryCaspase 1LipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinSesquiterpenesSignal TransductionAnimalsCell LineDisease Models, AnimalMaleMiceMice, Inbred C57BLOxidative StressPyroptosisCaspase 1LipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseSesquiterpeneszerumboneacute lung injurycaspase‐1GSDMDlipopolysaccharideNLRP3pyroptosiszerumbone

Identifiers

PMID41053917
PMCPMC12500414

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.